How to Initiate Fecal Microbiota Transplantation in Developing Countries Using the Behavior Economics Concept of “Choice Architecture”

Savigamin, Chatuthanai; Mahakit, Nuttida; Stithit, Suchinda; Samuthpongtorn, Chatpol

doi:10.3389/fmed.2021.746230

Cited by 2 publications

(2 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Positive perception of FMT, both for medical professionals and patients, can be promoted by applying the nudge principle (the main key of behavioral economics), which involves changing people’s behavior in order to make the best decision [ 5 , 17 ]. The increased interest in FMT has led specialists to carry out multiple studies to indicate the safety and effectiveness of this therapeutic operation.…”

Section: Studies On Fmt During the Covid-19 Pandemicmentioning

confidence: 99%

“…In order to directly modify the recipient’s microbial composition and provide a health benefit, fecal microbiota transplantation (FMT) involves administering a solution of fecal material from a donor into a recipient’s digestive tract [ 5 , 6 , 17 ]. Because of its clinical benefit of changing the gut microbiota of its receivers, FMT is regarded as the most cutting-edge approach to treating dysbiosis and its complications [ 4 , 5 , 18 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Therapeutic Perspectives for Microbiota Transplantation in Digestive Diseases and Neoplasia—A Literature Review

Boicean,

Bratu,

Bacila

et al. 2023

Pathogens

View full text Add to dashboard Cite

In a mutually beneficial connection with its host, the gut microbiota affects the host’s nutrition, immunity, and metabolism. An increasing number of studies have shown links between certain types of disease and gut dysbiosis or specific microorganisms. Fecal microbiota transplantation (FMT) is strongly advised for the treatment of recurrent or resistant Clostridium difficile infection (CDI) due to its outstanding clinical effectiveness against CDI. The therapeutic potential of FMT for other disorders, particularly inflammatory bowel diseases and malignancies, is currently gaining more and more attention. We summarized the most recent preclinical and clinical evidence to show the promise of FMT in the management of cancer as well as complications related to cancer treatment after reviewing the most recent research on the gut microbiota and its relationship to cancer.

show abstract

Section: Studies On Fmt During the Covid-19 Pandemicmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Therapeutic Perspectives for Microbiota Transplantation in Digestive Diseases and Neoplasia—A Literature Review

Boicean,

Bratu,

Bacila

et al. 2023

Pathogens

View full text Add to dashboard Cite

show abstract

Best Practices in the Management of Clostridioides difficile Infection in Developing Nations

Mendo-Lopez,

Alonso,

Villafuerte-Gálvez

2024

TropicalMed

View full text Add to dashboard Cite

Clostridioides difficile infection (CDI) is a well-known cause of hospital-acquired infectious diarrhea in developed countries, though it has not been a top priority in the healthcare policies of developing countries. In the last decade, several studies have reported a wide range of CDI rates between 1.3% and 96% in developing nations, raising the concern that this could represent a healthcare threat for these nations. This review defines developing countries as those with a human development index (HDI) below 0.8. We aim to report the available literature on CDI epidemiology, diagnostics, management, and prevention in developing countries. We identify limitations for CDI diagnosis and management, such as limited access to CDI tests and unavailable oral vancomycin formulation, and identify opportunities to enhance CDI care, such as increased molecular test capabilities and creative solutions for CDI. We also discuss infection prevention strategies, including antimicrobial stewardship programs and opportunities emerging from the COVID-19 pandemic, which could impact CDI care.

show abstract

How to Initiate Fecal Microbiota Transplantation in Developing Countries Using the Behavior Economics Concept of “Choice Architecture”

Cited by 2 publications

References 10 publications

Therapeutic Perspectives for Microbiota Transplantation in Digestive Diseases and Neoplasia—A Literature Review

Therapeutic Perspectives for Microbiota Transplantation in Digestive Diseases and Neoplasia—A Literature Review

Best Practices in the Management of Clostridioides difficile Infection in Developing Nations

Contact Info

Product

Resources

About